Orotate phosphoribosyl transferase mRNA expression in oral squamous cell carcinoma and its relationship with the dihydropyrimidine dehydrogenase expression and the clinical effect of 5-fluorouracil

Oral Oncology

Volumn 42, Issue 9, 2006, Pages 880-887

  Yoshitomi, Izumi ^a   Kawasaki, Goro ^a   Yanamoto, Souichi ^a   Mizuno, Akio ^a  

^a Division of Oral and Maxillofacial Surgery   (Japan)

Author keywords

5 Fluorouracil; Dihydropyrimidine dehydrogenase (DPD); Oral cancer; Orotate phosphoribosyl transferase (OPRT)

Indexed keywords

FLUOROURACIL; MESSENGER RNA; OROTATE PHOSPHORIBOSYLTRANSFERASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; NUCLEOTIDE SEQUENCE; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DIHYDROURACIL DEHYDROGENASE (NADP); ENZYME ACTIVATION; FEMALE; FLUOROURACIL; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; OROTATE PHOSPHORIBOSYLTRANSFERASE; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 33748888959     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2005.12.009     Document Type: Article

References (28)

1. Isshi K., Sakuyama T., Gen T., Nakamura Y., Kuroda T., Katuyama T., et al. Predicting 5-FU sensitivity using human colorectal cancer specimens: comparison of tumor dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activities with in vitro chemosensitivity to 5-FU. Int J Clin Oncol 7 6 (2002) 335-342
2. Mizutani Y., Wada H., Fukushima M., Yoshida O., Nakanishi H., Li Y.N., et al. Prognostic significance of orotate phosphoribosyl transferase activity in bladder carcinoma. Cancer 100 4 (2004) 723-731
3. Beck A., Etienne M.C., Cheradame S., Fischel J.L., Formento P., Renee N., et al. A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil. Eur J Cancer 30A 10 (1994) 1517-1522
4. Ishikawa Y., Kubota T., Otani Y., Watanabe M., Teramoto T., Kumai K., et al. Dihydropyrimidine dehydrogenase and messenger RNA levels in gastric cancer: possible predictor for sensitivity to 5-fluorouracil. Jpn J Cancer Res 91 (2000) 105-112
5. Kawasaki G., Yoshitomi I., Yanamoto S., and Mizuno A. Thymidylate synthase and dihydropyrimidine dehydrogenase expression in oral squamous cell carcinoma: an immunohistochemical and clinicopathologic study. Oral Surg Oral Med Oral Pathol 94 6 (2002) 717-723
6. Fujii R., Seshimo A., and Kameoka S. Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyl transferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma. Int J Clin Oncol 8 2 (2003) 72-78
7. Katsumata K., Sumi T., Murohashi T., Nagashima K., Uda O., Ashizawa T., et al. Analysis of the salvage synthesis within biosynthesis of nucleic acid route in colon cancer. Jpn J Cancer Chemother 27 9 (2000) 1415-1420
8. Ochiai T., Sugitani M., Nishimura K., Noguchi H., Watanabe T., Sengoku H., et al. Expression and pathophysiologic features of orotate phosphoribosyl transferase activity (OPRT) in gastric carcinoma. Jpn J Cancer Chemother 28 3 (2001) 345-350
9. Ochiai T., Sugitani M., Nishimura K., Noguchi H., Watanabe T., Sengoku H., et al. Correlation between 5-fluorouracil (5-FU) sensitivity as measured by collagen gel droplet embedded culture drug sensitivity test (CD-DST) and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer. Jpn J Cancer Chemother 28 5 (2001) 661-667
10. Ochiai T., Sugitani M., Nishimura K., Noguchi H., Watanabe T., Sengoku H., et al. Correlation between clinical pathophysiologic factors and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer. Jpn J Cancer Chemother 29 3 (2002) 413-420
11. Ochiai T., Sugitani M., Nishimura K., Noguchi H., Okada T., Suda S., et al. Correlation between enzymatic activity and gene expression of orotate phosphoribosyl transferase (OPRT) in colorectal cancer. Jpn J Cancer Chemother 29 13 (2002) 2515-2519
12. Takemura M., Osugi H., Lee S., Kaneko M., Tanaka Y., Fujiwara Y., et al. Choice of chemotherapeutic drugs for colorectal cancers by DPD and OPRT activities in cancer tissues. Jpn J Cancer Chemother 31 7 (2004) 1053-1056
13. Oguri T., Achiwa H., Bessho Y., Muramatsu H., Maeda H., Niimi T., et al. The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells. Lung Cancer 49 3 (2005) 345-351
14. Inaba M., Mitsuhashi J., Sawada H., Miike N., Naoe Y., Daimon A., et al. Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells. Jpn J Cancer Res 87 (1996) 212-220
15. Kuniyasu T., Nakamura T., Tabuchi Y., and Kuroda Y. Immunohistochemical evaluation of thymidylate synthase in gastric carcinoma using a new polyclonal antibody: the clinical role of thymidylate synthase as a prognostic indicator and its therapeutic usefulness. Cancer 83 7 (1998) 1300-1306
16. Salonga D., Danenberg K.D., Johnson M., Metzger R., Groshen S., Tsao-Wei D.D., et al. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res 6 4 (2000) 1322-1327
17. Ichikawa W., Uetake H., Shirota Y., Yamada H., Takahashi T., Nihei Z., et al. Both gene expression for orotate phosphoribosyl transferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer. Br J Cancer 89 8 (2003) 1486-1492
18. Shirasaka T., Shimamoto Y., and Fukushima M. Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats. Cancer Res 53 17 (1993) 4004-4009
19. Kanai F., Kawakami T., Hamada H., Sadata A., Yoshida Y., Tanaka T., et al. Adenovirus-mediated transduction of Escherichia coli uracil phosphoribosyltransferase gene sensitizes cancer cells to low concentrations of 5-fluorouracil. Cancer Res 58 9 (1998) 1946-1951
20. Jin C.D., Yamamoto T., Nakamura M., Arai I., Kishin R., Xing X., et al. Influence on 5-fluorouracil metabolism by combination of interferon-alpha and 5-fluorouracil against human hepatocellular carcinoma xenografts. Jpn J Cancer Chemother 31 10 (2004) 1511-1515
21. Krungkrai S.R., Prapunwattana P., Horii T., and Krungkrai J. Orotate phosphoribosyl transferase and orotidine 5′-monophosphate decarboxylase exist as multienzyme complex in human malaria parasite Plasmodium falciparum. Biochem Biophys Res Commun 318 4 (2004) 1012-1018
22. Hidaka S., Yasutake T., Fukushima M., Yano H., Haseba M., Tsuji T., et al. Chromosomal imbalances associated with acquired resistance to fluoropyrimidines in human colorectal cancer cells. Eur J Cancer 39 7 (2003) 975-980
23. Park J.S., Young Yoon S., Kim J.M., Yeom Y.I., Kim Y.S., and Kim N.S. Identification of novel genes associated with the response to 5-FU treatment in gastric cancer cell lines using a cDNA microarray. Cancer Lett 214 1 (2004) 19-33
24. Furuse H., Hirano Y., Harada M., Mugiya S., Ushiyama T., Suzuki K., et al. Orotate phosphoribosyl transferase in bladder cancer. Jpn J Cancer Chemother 31 6 (2004) 1431-1433
25. Miyoshi Y., Uemura H., Ishiguro H., Kitamura H., Nomura N., Danenberg P.V., et al. Expression of thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, and orotate phosphoribosyl transferase in prostate cancer. Prostate Cancer Prostatic Dis 8 3 (2005) 260-265
26. Ikenaka K., Fukushima M., Nakamura H., Okamoto M., Shirasaka T., and Fujii S. Metabolism of pyrimidine nucleotides in various tissues and tumor cells from rodents. Gann 72 (1981) 590-597
27. Maehara Y., Moriguchi S., Emi Y., Watanabe A., Kohnoe S., Tsujitani S., et al. Comparison of pyrimidine nucleotide synthetic enzymes involved in 5-fluorouracil metabolism between human adenocarcinomas and squamous cell carcinomas. Cancer 66 1 (1990) 156-161
28. Peters G.J., van Groeningen C.J., Laurensse E.J., and Pinedo H.M. A comparison of 5-fluorouracil metabolism in human colorectal cancer and colon mucosa. Cancer 68 9 (1991) 1903-1909